Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
New facility is part of Aptar Pharma’s global expansion program
GMM Pfaudler US completes acquisition of MixPro
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
The company is confident of addressing all the observations within the stipulated time
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
